Skip to main navigation Skip to search Skip to main content

AN OPEN-LABEL STUDY OF MKC-442 IN COMBINATION WITH NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS IN HIV-1 INFECTED...

Project: Research

Project Details

StatusFinished
Effective start/end date01/4/99 → 11/7/02

Funding

  • Triangle Pharmaceuticals Incorporated: $32,428.20